Free Trial

Enlivex Therapeutics (ENLV) Short Interest Ratio & Short Volume

Enlivex Therapeutics logo
$1.13 -0.02 (-1.74%)
As of 01/17/2025 04:00 PM Eastern

Enlivex Therapeutics Short Interest Data

Enlivex Therapeutics (ENLV) has a short interest of 125,200 shares. This marks a -41.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 109,444 shares to cover all short positions.

Current Short Interest
125,200 shares
Previous Short Interest
212,900 shares
Change Vs. Previous Month
-41.19%
Dollar Volume Sold Short
$146,484.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
21,410,000 shares
Percentage of Shares Shorted
0.58%
Today's Trading Volume
45,575 shares
Average Trading Volume
109,444 shares
Today's Volume Vs. Average
42%
Short Selling Enlivex Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Enlivex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENLV Short Interest Over Time

ENLV Days to Cover Over Time

ENLV Percentage of Float Shorted Over Time

Enlivex Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2024125,200 shares $146,484.00 -41.2%N/A0.5 $1.17
12/15/2024212,900 shares $255,480.00 -0.9%N/A0.9 $1.20
11/30/2024214,800 shares $244,872.00 +116.5%N/A0.9 $1.14
11/15/202499,200 shares $106,144.00 -38.0%N/A0.7 $1.07
10/31/2024160,100 shares $216,135.00 +58.7%N/A1.4 $1.35
10/15/2024100,900 shares $156,395.00 -3.5%N/A1.1 $1.55
9/30/2024104,600 shares $175,728.00 -23.1%N/A1.4 $1.68
9/15/2024136,100 shares $213,677.00 +43.9%N/A1.9 $1.57
8/31/202494,600 shares $122,980.00 +26.6%N/A1.9 $1.30
8/15/202474,700 shares $91,134.00 -11.7%N/A1.3 $1.22
7/31/202484,600 shares $113,364.00 -27.4%N/A1.4 $1.34
7/15/2024116,500 shares $164,265.00 -0.6%N/A1.6 $1.41
6/30/2024117,200 shares $166,424.00 -16.8%N/A0.7 $1.42
6/15/2024140,800 shares $205,568.00 -10.5%N/A0.8 $1.46
5/31/2024157,300 shares $213,928.00 -31.8%N/A0.9 $1.36
5/15/2024230,600 shares $327,452.00 -12.4%N/A1.3 $1.42
4/30/2024263,200 shares $439,544.00 -5.6%N/A1.5 $1.67
4/15/2024278,700 shares $362,310.00 +17.9%N/A1.6 $1.30
3/31/2024236,400 shares $895,956.00 -9.6%N/A2.7 $3.79
3/15/2024261,500 shares $1.07 million +15.4%N/A2.4 $4.11
2/29/2024226,600 shares $703,593.00 +51.2%N/A2.2 $3.11
2/15/2024149,900 shares $481,179.00 -6.6%N/A1.6 $3.21
1/31/2024160,500 shares $449,400.00 -13.7%N/A1.9 $2.80
1/15/2024185,900 shares $533,533.00 +32.5%N/A2.3 $2.87
12/31/2023140,300 shares $378,810.00 +36.0%N/A1.8 $2.70
12/15/2023103,200 shares $145,512.00 -6.3%N/A1.9 $1.41
11/30/2023110,100 shares $202,584.00 -0.9%N/A3.5 $1.84
11/15/2023111,100 shares $194,425.00 -6.2%N/A3.6 $1.75
10/31/2023118,400 shares $157,472.00 +13.1%N/A3.9 $1.33
10/15/2023104,700 shares $147,627.00 -8.1%N/A4.1 $1.41
9/30/2023113,900 shares $179,962.00 +4.4%N/A4.5 $1.58
9/15/2023109,100 shares $206,199.00 +3.4%N/A4.2 $1.89
8/31/2023105,500 shares $252,145.00 -9.3%N/A4.8 $2.39
8/15/2023116,300 shares $303,543.00 +2.4%N/A5.1 $2.61
7/31/2023113,600 shares $290,816.00 +8.6%N/A4.9 $2.56
7/15/2023104,600 shares $248,948.00 +2.5%N/A4.8 $2.38
6/30/2023102,100 shares $268,247.33 -20.2%N/A3.6 $2.63
6/15/2023128,000 shares $362,240.00 +5.6%N/A3.6 $2.83
5/31/2023121,200 shares $316,332.00 -5.8%N/A3.5 $2.61
5/15/2023128,700 shares $359,073.00 -1.2%N/A3.8 $2.79
Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
4/30/2023130,200 shares $369,768.00 -4.6%N/A3.7 $2.84
4/15/2023136,400 shares $396,924.00 -15.7%N/A3.6 $2.91
3/31/2023161,700 shares $588,588.00 +0.5%N/A4.3 $3.64
3/15/2023160,900 shares $577,631.00 -1.3%N/A5.9 $3.59
2/28/2023163,000 shares $652,000.00 +0.9%N/A5.7 $4.00
2/15/2023161,500 shares $673,455.00 -8.8%N/A5.5 $4.17
1/31/2023177,100 shares $775,698.00 -2.9%N/A5.8 $4.38
1/15/2023182,300 shares $796,505.16 -4.8%N/A6.9 $4.37
12/30/2022191,400 shares $753,637.50 -0.5%N/A7.8 $3.94
12/15/2022192,400 shares $779,220.00 -11.5%N/A9.2 $4.05
11/30/2022217,500 shares $996,998.25 +16.9%N/A9 $4.58
11/15/2022186,000 shares $894,660.00 +0.1%N/A6.9 $4.81
10/31/2022185,800 shares $797,082.00 -3.8%N/A6.6 $4.29
10/15/2022193,100 shares $805,227.00 +1.2%N/A5.4 $4.17
9/30/2022190,900 shares $811,325.00 +4.5%N/A4.4 $4.25
9/15/2022182,700 shares $959,175.00 -5.4%N/A3.9 $5.25
8/31/2022193,100 shares $1.01 million -7.0%N/A4.2 $5.25
8/15/2022207,700 shares $1.08 million -9.5%N/A4.4 $5.22
7/31/2022229,600 shares $975,800.00 -8.4%N/A4 $4.25
7/15/2022250,600 shares $1.23 million -9.8%N/A3.8 $4.91
6/30/2022277,700 shares $1.26 million -2.3%N/A3.5 $4.52
6/15/2022284,300 shares $1.16 million -0.3%N/A3.5 $4.07
5/31/2022285,000 shares $1.43 million -9.2%N/A3.5 $5.01
5/15/2022313,900 shares $1.34 million -9.6%N/A4.1 $4.28
4/30/2022347,200 shares $1.98 million -3.9%N/A4.7 $5.69
4/15/2022361,300 shares $2.67 million +15.0%N/A5.9 $7.39
3/31/2022314,200 shares $1.76 million -2.2%N/A5.3 $5.59
3/15/2022321,300 shares $1.63 million -10.4%N/A5.3 $5.06
2/28/2022358,500 shares $1.92 million -4.0%N/A4.9 $5.35
2/15/2022373,500 shares $1.99 million +2.8%N/A4.7 $5.34
1/31/2022363,200 shares $1.94 million +8.2%N/A4.2 $5.34
1/15/2022335,700 shares $1.97 million -8.3%N/A3.7 $5.87
12/31/2021365,900 shares $2.29 million +0.1%N/A4.2 $6.25
12/15/2021365,400 shares $2.40 million -3.6%N/A4.4 $6.56
11/30/2021379,000 shares $2.65 million +7.0%N/A5 $7.00
11/15/2021354,200 shares $2.91 million +9.9%N/A3.5 $8.21
10/29/2021322,200 shares $2.65 million +4.5%N/A1 $8.24
10/15/2021308,300 shares $2.86 million -13.0%N/A0.9 $9.28
9/30/2021354,300 shares $3.50 million -8.0%N/A1.1 $9.88
9/15/2021385,200 shares $4.21 million -8.0%N/A1.2 $10.92
8/31/2021418,500 shares $5.80 million +114.2%N/A1.3 $13.86
8/13/2021195,400 shares $1.99 million +38.0%N/A0.7 $10.17
7/30/2021141,600 shares $1.08 million No Change1.2%2.1 $7.60
7/15/2021141,600 shares $1.07 million +0.9%1.2%1.8 $7.54
6/30/2021140,400 shares $1.25 million +4.0%1.2%1.6 $8.90
6/15/2021135,000 shares $1.32 million +14.9%1.1%1.5 $9.80
5/28/2021117,500 shares $1.10 million -28.6%1.0%1.1 $9.37
5/14/2021164,500 shares $1.42 million +26.4%N/A1.1 $8.61
4/30/2021130,100 shares $1.57 million +94.2%N/A0.3 $12.10
4/15/202167,000 shares $725,610.00 -18.8%N/A0.2 $10.83
This Crypto Is Set to Explode in January (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

3/31/202182,500 shares $874,500.00 -17.6%N/A0.2 $10.60
3/15/2021100,100 shares $1.44 million +5.2%1.0%0.2 $14.40
2/26/202195,200 shares $1.44 million +64.4%1.1%0.2 $15.11
2/12/202157,900 shares $1.22 million -76.6%0.7%0.1 $21.09
1/29/2021246,900 shares $2.93 million +13.8%3.2%0.7 $11.85
1/15/2021217,000 shares $2.23 million +7.1%2.9%1 $10.29
12/31/2020202,600 shares $1.87 million -24.9%2.7%0.7 $9.22
12/15/2020269,700 shares $2.65 million +165.2%3.5%0.2 $9.83
11/30/2020101,700 shares $876,654.00 -38.2%1.3%0.1 $8.62
11/15/2020164,600 shares $1.53 million -13.1%2.2%0.1 $9.28
10/30/2020189,500 shares $2.23 million -53.7%2.5%0.2 $11.75
10/15/2020408,900 shares $5.41 million +1,497.3%5.4%0.4 $13.23
9/30/202025,600 shares $152,064.00 +22.5%0.3%0 $5.94
9/15/202020,900 shares $108,262.00 -57.1%0.3%0.3 $5.18
8/31/202048,700 shares $252,753.00 +429.4%0.6%0.5 $5.19
8/14/20209,200 shares $48,668.00 -59.1%0.1%0.1 $5.29
7/31/202022,500 shares $122,850.00 +10.3%0.3%0.2 $5.46
7/15/202020,400 shares $104,040.00 +88.9%0.3%0.2 $5.10
6/30/202010,800 shares $65,448.00 -6.1%0.1%0.1 $6.06
6/15/202011,500 shares $62,560.00 -48.0%0.2%0.1 $5.44
5/29/202022,100 shares $117,130.00 +71.3%0.3%0.2 $5.30
5/15/202012,900 shares $62,178.00 +152.9%0.2%0.1 $4.82
4/30/20205,100 shares $27,999.00 -67.1%0.1%0 $5.49
4/15/202015,500 shares $86,800.00 -17.6%0.2%0.1 $5.60
3/31/202018,800 shares $105,468.00 -69.6%0.3%0.1 $5.61
3/13/202061,900 shares $282,264.00 +302.0%1.4%0.2 $4.56
2/28/202015,400 shares $63,448.00 -54.0%0.3%0.1 $4.12
2/14/202033,500 shares $192,960.00 +805.4%0.8%0.5 $5.76
1/31/20203,700 shares $31,450.00 -32.7%0.1%0.2 $8.50

ENLV Short Interest - Frequently Asked Questions

What is Enlivex Therapeutics' current short interest?

Short interest is the volume of Enlivex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 125,200 shares of ENLV short. Learn More on Enlivex Therapeutics' current short interest.

Is Enlivex Therapeutics' short interest increasing or decreasing?

Enlivex Therapeutics saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 125,200 shares, a drop of 41.2% from the previous total of 212,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Enlivex Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enlivex Therapeutics: MediciNova, Inc. (0.78%), X4 Pharmaceuticals, Inc. (7.83%), Immunic, Inc. (6.26%), Editas Medicine, Inc. (22.06%), Acumen Pharmaceuticals, Inc. (3.46%), Oramed Pharmaceuticals Inc. (0.60%), 23andMe Holding Co. (6.80%), Cellectis S.A. (0.37%), Atara Biotherapeutics, Inc. (12.38%), PepGen Inc. (2.64%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Enlivex Therapeutics stock?

Short selling ENLV is an investing strategy that aims to generate trading profit from Enlivex Therapeutics as its price is falling. ENLV shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enlivex Therapeutics?

A short squeeze for Enlivex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENLV, which in turn drives the price of the stock up even further.

How often is Enlivex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENLV, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:ENLV) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners